Product description

Biolevox™ HA ONE 2.5% is a hyaluronic acid gel for an intraarticular injections in a 4.8 ml pre-filled syringe. Sodium hyaluronate obtained by bacterial fermentation is used as a viscoelastic gel in osteoarthritic joint. Hyaluronic acid role in joint is to facilitate the joint movement, relief pain, protect intra-articular cartilage and stimulate the production of endogenous hyaluronic acid.As a one of the few on the market, it has the highest content of hyaluronic acid in a single dose.

Read more

Specifications

Categories Finished Dosage FormsInjectables; BiopharmaceuticalsRegenerative Medicine
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Poland
Measured In piece
Selling Points Bone & Joint Health; Brand Name
Biolevox™ HA ONE 2.5%

Contact information

Address

Telephone

Website

View all contact information
CAPSULE CORE COMPETENCY

CAPSULE CORE COMPETENCY

Curia - From Curiosity to Cure

Curia - From Curiosity to Cure

Alfasigma  Contract Manufacturing Showroom

Alfasigma Contract Manufacturing Showroom

Wavelength Pharmaceuticals

Wavelength Pharmaceuticals

Datwyler Pharma Packaging

Datwyler Pharma Packaging